Effects of angiotensin-converting enzyme inhibitor therapy on QT dispersion post acute myocardial infarction

PACE - Pacing and Clinical Electrophysiology

Volumn 26, Issue 4, 2003, Pages 843-848

  Kassotis, John ^a,b   Mongwa, Mbu ^a   Reddy, C V R ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b NEW YORK METHODIST HOSPITAL   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Arrhythmias; QT dispersion; Sudden cardiac death

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; QT INTERVAL; RETROSPECTIVE STUDY; SUDDEN DEATH;

EID: 0037387505     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.t01-1-00148.x     Document Type: Article

References (22)

1. Pfeffer MA, Braunwald E, Moys LA, et al. Effect of captopril on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992; 327:725-727.
2. Pouleur H, Rousseau MF, Van Syll C, et al. Effects of long term enalapril therapy on left ventricular diastolic properties in patients with depressed ejection fraction. SOLVD Investigators. Circulation 1993; 88:481-491.
3. Sewdberg K, Kiekshus J. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). Am J Cardiol 1988; 62:60A-66A.
4. Cohn JN, Johnson G, Ziesihe S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325:303-310.
5. Pitt B. Evaluation of Losartan in Elderly Study (ELITE). Lancet 1997; 349:747-753.
6. Ambrosioni E, Broghi C, Magnani B, for the Survival of Myocardial Infarction Long-term Evaluation (SMILE) Study Investigators. The effects of angiotensin converting enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med 1995; 332:80-85.
7. Kober L, Torp-Pederson C, Carlsen JE, et al. A clinical trial of the angiotensin converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995; 333:1670-1676.
8. Pfeffer MA, Creaves SC, Arnold JM, et al. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The Healing and Early Afterload Reducing Therapy Trial. Circulation 1997; 95:2643-2651.
9. Domanski MJ, Exner DV, Borkowf CB, et al. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials. J Am Coll Cardiol 1999; 33:598-604.
10. Juha S, Perkiömäki M, Juhani K, et al. Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. J Am Coll Cardiol 1995; 26:174-179.
11. Barr CS, Naas C, Freeman M, et al. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994; 343:327-329.
12. Mayet J, Shahi M, McGrath K, et al. Left ventricular hypertrophy and QT dispersion in hypertension. Hypertension 1996; 28:791-796.
13. Sousa MJ, Aranha J, Cotrim C, et al. The QTc interval and its dispersion in hypertrophic cardiomyopathy - its relation to complex ventricular arrhythmias and the effect of anti-arrhythmia agents. [in Portuguese] Revista Portuguesa de Cardiologia 1995; 14:447-448, 461-467.
14. Spargias KS, Lindsey SJ, Hall AS, et al. Ramipril reduces QT dispersion in patients with acute myocardial infarction and heart failure. Am J Cardiol 1999; 83:969-971.
15. White HD, Norris RM, Brown MA, et al. Left ventricular endsystolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987; 76:44-51.
16. Multicenter Post Infarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983; 309:331-336.
17. Kuo CS, Atarashi H, Reddy CP, et al. Dispersion of ventricular repolarization and arrhythmia: Study of two consecutive ventricular premature complexes. Circulation 1985; 72:370-376.
18. Kuo CS, Reddy CP, Munakata K, et al. Mechanism of ventricular arrhythmias caused by increased dispersion of repolarization. Eur Heart J 1985; 6(Suppl. D):63-70.
19. Bigger JT Jr, Fleiss JL, Kleiger R, et al. The relationships among ventricular arrhythmias, left ventricular dysfunction and mortality in the 2 years after myocardial infarction. Circulation 1984; 69:250-258.
20. Glancy JM, Garratt CJ, DP. Dynamics of QT dispersion during myocardial infarction and ischemia. Int J Cardiol 1996; 57:55-60.
21. Gruppo Italiano per lo Studio della Sopravvivenza Nell'Infarto Miocardio. GISSI-3: Effects of lisinopril and transdermal glycerly trinitrate singly and together on 6 week mortality and ventricular function after acute myocardial infarction. Lancet 1994; 343:1115-1122.
22. Whang J, Ramasamy R, Dizon JM, et al. Enalaprilat attenuates ischemic rise in intracellular sodium in the isolated rat heart via the bradykinin receptor. J Cardiovasc MR 2001; 3:27-34.